Denmark’s Genmab files for $500M Nasdaq listing in US
Published on: Wednesday 29 May 2019
A Danish drugmaker is looking to list its shares on the Nasdaq. Copenhagen-based Genmab said Tuesday that it had filed a Form F-1 with the Securities and Exchange Commission for a potential ...
